NYSEAMERICAN:CTEK

CynergisTek Stock Forecast, Price & News

$1.95

-0.11 (-5.34 %)

(As of 06/18/2021 12:00 AM ET)

Add

Compare

Today's Range

$1.95

▼

$2.08

50-Day Range

$1.37

▼

$1.59

52-Week Range

$0.96

▼

$2.90

Volume67,354 shs

Average Volume190,102 shs

Market Capitalization$23.64 million

P/E RatioN/A

Dividend YieldN/A

Beta1.26

30 days | 90 days | 365 days | Advanced Chart

Receive CTEK News and Ratings via Email

Sign-up to receive the latest news and ratings for CynergisTek and its competitors with MarketBeat's FREE daily newsletter.

About CynergisTek

CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company offers assessment and audit, technical testing, remediation, management, and validation services. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.

Is CynergisTek, Inc. (CTEK) A Good Stock To Buy? - Yahoo Finance
June 18, 2021 | finance.yahoo.com

Defenseforce Brings Automation to CMMC; Enables CMMC Practitioners, Assessors, and Defense Contractors to Generate Initial GAP Analysis in Less Than 24 Hours - StreetInsider.com
June 16, 2021 | streetinsider.com

KTL Solutions Customer Becomes First Authorized C3PAO
June 14, 2021 | finance.yahoo.com

Short Interest in CynergisTek, Inc. (NYSEAMERICAN:CTEK) Drops By 46.5%
June 13, 2021 | americanbankingnews.com

Riot Blockchain and Atomera among tech gainers; MoSys and Comtech Telecommunications among losers - Seeking Alpha
June 9, 2021 | seekingalpha.com

CLEANTECH INNOVATION (CTEK), Microsoft Corporation (NASDAQ:MSFT) - CynergisTek Unit Redspin Nails DoD's Cybersecurity Certification - Benzinga
June 9, 2021 | benzinga.com

CynergisTek (NYSEAMERICAN:CTEK) Trading Up 1.7%
June 5, 2021 | americanbankingnews.com

CynergisTek Teams Up with Blackbaud to Offer HIPAA Advisory Services for Blackbaud’s Healthcare Clients - Yahoo Finance
May 17, 2021 | finance.yahoo.com

CynergisTek Teams Up with Blackbaud to Offer HIPAA Advisory Services for Blackbaud’s Healthcare Clients
May 17, 2021 | finance.yahoo.com

CynergisTek, Inc. (CTEK) CEO William Barlow on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
May 14, 2021 | seekingalpha.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNYSEAMERICAN:CTEK
Previous SymbolNYSEMKT:CTEK
CUSIPN/A
CIK1011432
Webwww.cynergistek.com
Phone949-614-0700
Employees107
Year FoundedN/A

Sales & Book Value

Annual Sales$18.87 million
Price / Sales1.25
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.20 per share
Price / Book0.89

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares12,121,000
Market Cap$23.64 million
Next Earnings Date8/12/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.63 out of 5 stars

Business Services Sector

329th out of 505 stocks

Business Services, Not Elsewhere Classified Industry

128th out of 204 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CynergisTek.

2.5 Community Rank

Outperform Votes
CynergisTek has received 149 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CynergisTek has received 154 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CynergisTek has received 50.83% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CynergisTek and other stocks. Vote “Outperform” if you believe CTEK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CTEK will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CynergisTek does not currently pay a dividend.
Dividend Growth
CynergisTek does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CynergisTek insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 15.00% of the stock of CynergisTek is held by insiders.
Percentage Held by Institutions
Only 22.78% of the stock of CynergisTek is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of CynergisTek is -1.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of CynergisTek is -1.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
CynergisTek has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions

What stocks does MarketBeat like better than CynergisTek?

Wall Street analysts have given CynergisTek a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CynergisTek wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting CynergisTek?

CynergisTek saw a decline in short interest in May. As of May 28th, there was short interest totaling 74,100 shares, a decline of 46.5% from the May 13th total of 138,500 shares. Based on an average daily volume of 167,300 shares, the days-to-cover ratio is presently 0.4 days.
View CynergisTek's Short Interest.

When is CynergisTek's next earnings date?

CynergisTek is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for CynergisTek.

How were CynergisTek's earnings last quarter?

CynergisTek, Inc. (NYSEAMERICAN:CTEK) posted its quarterly earnings results on Wednesday, May, 12th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.06. CynergisTek had a negative net margin of 97.78% and a negative trailing twelve-month return on equity of 58.81%.
View CynergisTek's earnings history.

How has CynergisTek's stock been impacted by Coronavirus (COVID-19)?

CynergisTek's stock was trading at $2.53 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CTEK stock has decreased by 22.9% and is now trading at $1.95.
View which stocks have been most impacted by COVID-19.

Who are CynergisTek's key executives?

CynergisTek's management team includes the following people:

Mr. William Caleb Barlow, CEO, Pres & Director (Age 49, Pay $505.92k)
Mr. Michael H. McMillan CISM, FHIMSS, Founder & Director (Age 64, Pay $21.88k)
Mr. Paul T. Anthony, CFO, Corp. Sec. & Treasurer (Age 50, Pay $315.84k)
Mr. Benjamin Denkers, Exec. VP of Strategy & Operations
Mr. Bryan Flynn, Head of Investor Relations
Ms. Carrie Mulcahy, VP of Marketing
Mr. Steven Rivera, Sr. VP of Sales
Mr. Rafael Lammie, VP of People & Culture
Mr. David Finn, Exec. VP of External Affairs, Information Systems & Security
Mr. Michael McCune, Sales Exec.

Who are some of CynergisTek's key competitors?

Some companies that are related to CynergisTek include Heritage Global (HGBL), Iota Communications (IOTC), Exela Technologies (XELA), OmniComm Systems (OMCM), Research Solutions (RSSS), Global Internet of People (SDH), Viper Networks (VPER), ALJ Regional (ALJJ), TuanChe (TC), China Recycling Energy (CREG), DynTek (DYNE), Logiq (LGIQ), Solbright Group (SBRT), Protagenic Therapeutics (PTIX) and SilverSun Technologies (SSNT).
View all of CTEK's competitors.

What other stocks do shareholders of CynergisTek own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include SeaChange International (SEAC), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Invesco (IVZ), VBI Vaccines (VBIV), Actinium Pharmaceuticals (ATNM), Centennial Resource Development (CDEV), Genocea Biosciences (GNCA), Inovio Pharmaceuticals (INO) and Matinas BioPharma (MTNB).

What is CynergisTek's stock symbol?

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

Who are CynergisTek's major shareholders?

CynergisTek's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Essex Investment Management Co. LLC (1.86%), Renaissance Technologies LLC (1.53%), Perkins Capital Management Inc. (1.53%), Citadel Advisors LLC (0.47%), Citadel Advisors LLC (0.47%) and Virtu Financial LLC (0.16%). Company insiders that own CynergisTek stock include Dana Davis Sellers, John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony, Robert Mccashin and William Caleb Barlow.
View institutional ownership trends for CynergisTek.

Which institutional investors are buying CynergisTek stock?

CTEK stock was purchased by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Citadel Advisors LLC, Citadel Advisors LLC, Essex Investment Management Co. LLC, Renaissance Technologies LLC, and Virtu Financial LLC. Company insiders that have bought CynergisTek stock in the last two years include Dana Davis Sellers, John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony, Robert Mccashin, and William Caleb Barlow.
View insider buying and selling activity for CynergisTek or or view top insider-buying stocks.

How do I buy shares of CynergisTek?

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CynergisTek's stock price today?

One share of CTEK stock can currently be purchased for approximately $1.95.

How much money does CynergisTek make?

CynergisTek has a market capitalization of $23.64 million and generates $18.87 million in revenue each year.

How many employees does CynergisTek have?

CynergisTek employs 107 workers across the globe.

What is CynergisTek's official website?

The official website for CynergisTek is www.cynergistek.com.

Where are CynergisTek's headquarters?

CynergisTek is headquartered at 11940 JOLLYVILLE ROAD SUITE 300N, AUSTIN TX, 78759.

How can I contact CynergisTek?

CynergisTek's mailing address is 11940 JOLLYVILLE ROAD SUITE 300N, AUSTIN TX, 78759. The company can be reached via phone at 949-614-0700 or via email at [email protected]

This page was last updated on 6/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here